Hepatitis C and HIV Coinfection for Social Workers in Public Health, Medical and Substance Use Treatment Settings

Soc Work Public Health. 2015;30(4):325-35. doi: 10.1080/19371918.2014.1000506. Epub 2015 Mar 26.

Abstract

Hepatitis C virus (HCV) infection is a leading cause of liver disease and liver-related deaths among those living with human immunodeficiency virus (HIV) infection. Due to recent pharmacologic advancements with direct acting antivirals, if detected and treated, HCV antiviral therapy can prevent liver disease progression and permanently cure coinfected patients of HCV. The objectives of this article are to inform public health social workers and social workers in medical and substance use treatment settings of the public health burden of HCV/HIV coinfection and to highlight state-of-the art pharmacologic advancements in HCV antiviral therapy.

Keywords: HIV; Hepatitis C; liver disease; public health; social workers; testing; treatment.

Publication types

  • Research Support, N.I.H., Extramural
  • Review

MeSH terms

  • Anti-HIV Agents / therapeutic use
  • Antiviral Agents / therapeutic use
  • Coinfection / epidemiology*
  • HIV Infections / complications*
  • HIV Infections / diagnosis
  • HIV Infections / drug therapy
  • HIV Infections / epidemiology*
  • Hepatitis C / complications*
  • Hepatitis C / diagnosis
  • Hepatitis C / drug therapy
  • Hepatitis C / epidemiology*
  • Humans
  • Public Health
  • Social Workers*
  • Substance Abuse Treatment Centers

Substances

  • Anti-HIV Agents
  • Antiviral Agents